<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> is an <z:hpo ids='HP_0000006'>autosomal dominant</z:hpo> <z:e sem="disease" ids="C0410787" disease_type="Disease or Syndrome" abbrv="">heritable connective tissue disorder</z:e> which involves primarily the skeletal, ocular and cardiovascular system </plain></SENT>
<SENT sid="1" pm="."><plain>The incidence of MS is on average 1: 10000 with 25-30% of cases caused by <z:hpo ids='HP_0003745'>sporadic</z:hpo> mutations.The leading cause of premature <z:hpo ids='HP_0011420'>death</z:hpo> in these patients is progressive <z:mpath ids='MPATH_66'>dilatation</z:mpath> and subsequent dissection of the ascending thoracic aorta resulting in <z:e sem="disease" ids="C0007177" disease_type="Disease or Syndrome" abbrv="">cardiac tamponade</z:e>, and <z:e sem="disease" ids="C0023212" disease_type="Disease or Syndrome" abbrv="">left ventricular failure</z:e> due to <z:hpo ids='HP_0001659'>aortic regurgitation</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Life expectancy is primarily determined by the severity of cardiovascular involvement, and has improved substantially over the last 20 years due to the advances in surgical and medical management.The optimum management of Marfan patients includes a lifelong surveillance with particular emphasis placed on aortic behaviour </plain></SENT>
<SENT sid="3" pm="."><plain>Preventive replacement of various portions of the aorta has been a major contribution for improved life expectancy in these patients </plain></SENT>
<SENT sid="4" pm="."><plain>The different surgical and interventional treatment options currently available will be further outlined in this review </plain></SENT>
</text></document>